SCHEMBL13963545

SCHEMBL13963545

CC(=O)Nc1cccc2ccc(C)cc12

nearest known ligand 0.57

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
▸ ALDH1A1 P00352 4/20 0.57
▸ HPGD P15428 3/20 0.57
▸ KDM4E B2RXH2 2/20 0.57
▸ MAPT P10636 1/20 0.57
▸ TRPV1 Q8NER1 3/20 0.55
▸ POLB P06746 1/20 0.52
▸ CASP6 P55212 1/20 0.52
▸ KMT2A Q03164 2/20 0.51
▸ RAB9A P51151 1/20 0.51
▸ PLAU P00749 1/20 0.50
▸ HSD17B10 Q99714 1/20 0.50
▸ CYP1A2 P05177 1/20 0.50
▸ CYP2A6 P11509 1/20 0.50
▸ GLA P06280 1/20 0.47
▸ GAA P10253 1/20 0.47
▸ LMNA P02545 1/20 0.47
▸ TSHR P16473 1/20 0.47
▸ MEN1 O00255 1/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13963594 0.87 CASP6 (0.64) ALDH1A1HPGDKDM4EMAPTTRPV1
SCHEMBL13588247 0.84 TRPV1 (0.50) ALDH1A1HPGDKDM4EMAPTTRPV1
SCHEMBL30125341 0.83 TRPV1 (0.64) KDM4EMAPTTRPV1KMT2ARAB9A
SCHEMBL1805888 0.83 KDM4E (0.57) ALDH1A1HPGDKDM4EMAPTTRPV1
SCHEMBL1413170 0.83 TRPV1 (0.64) KDM4EMAPTTRPV1KMT2ARAB9A
SCHEMBL26885010 0.83 TRPV1 (0.54) ALDH1A1HPGDKDM4EMAPTTRPV1
SCHEMBL19417366 0.82 KDM4E (0.55) ALDH1A1HPGDKDM4EMAPTTRPV1
SCHEMBL8755640 0.81 PLAU (0.55) ALDH1A1HPGDKDM4EMAPTTRPV1
SCHEMBL357522 0.80 KDM4E (0.69) ALDH1A1HPGDKDM4EMAPTPOLB
SCHEMBL29514721 0.80 KDM4E (0.69) ALDH1A1HPGDKDM4EMAPTPOLB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9000010-B2 Alkyl-heterocycle carbamate derivatives, their preparation and their therapeutic application SANOFI (FR) 2015-04-07 — — US disclosed
US-9000010-B2 Alkyl-heterocycle carbamate derivatives, their preparation and their therapeutic application SANOFI (FR) 2015-04-07 — — US disclosed
US-20120295909-A1 ALKYL-HETEROCYCLE CARBAMATE DERIVATIVES, THEIR PREPARATION AND THEIR THERAPEUTIC APPLICATION SANOFI (FR) 2012-11-22 — — US disclosed
US-20120295909-A1 ALKYL-HETEROCYCLE CARBAMATE DERIVATIVES, THEIR PREPARATION AND THEIR THERAPEUTIC APPLICATION SANOFI (FR) 2012-11-22 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120295909-A1 ALKYL-HETEROCYCLE CARBAMATE DERIVATIVES, THEIR PREPARATION AND THEIR THERAPEUTIC APPLICATION PRMT9, PRMT8, CBR1 ALDH1A1 1706/4885HPGD 2301/4885KDM4E 797/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback